🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 11 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/08/2016 | 82,86 | 83,36 | 82,27 | 83,06 | +0,35% | 1,31% | 625.972 |
| 02/08/2016 | 86,43 | 86,83 | 82,71 | 82,77 | -4,22% | 4,76% | 755.173 |
| 01/08/2016 | 84,80 | 87,21 | 84,14 | 86,42 | +2,71% | 3,61% | 631.742 |
| 29/07/2016 | 83,94 | 85,03 | 82,78 | 84,14 | -0,01% | 2,69% | 823.621 |
| 28/07/2016 | 85,15 | 86,49 | 84,04 | 84,15 | -0,87% | 2,88% | 550.791 |
| 27/07/2016 | 84,10 | 84,96 | 83,31 | 84,88 | +1,36% | 1,97% | 410.528 |
| 26/07/2016 | 83,34 | 84,22 | 82,46 | 83,75 | +0,49% | 2,10% | 648.414 |
| 25/07/2016 | 82,86 | 83,79 | 82,15 | 83,34 | +0,79% | 1,98% | 407.643 |
| 22/07/2016 | 82,23 | 84,02 | 82,08 | 82,69 | +0,45% | 2,36% | 493.884 |
| 21/07/2016 | 84,95 | 86,68 | 81,41 | 82,32 | -2,34% | 6,20% | 835.484 |
| 20/07/2016 | 80,59 | 84,83 | 80,10 | 84,29 | +5,52% | 5,88% | 1.602.519 |
| 19/07/2016 | 78,70 | 80,39 | 78,11 | 79,88 | +1,63% | 2,90% | 638.475 |
| 18/07/2016 | 77,95 | 78,84 | 77,84 | 78,60 | -0,02% | 1,29% | 428.482 |
| 15/07/2016 | 80,77 | 80,90 | 78,31 | 78,62 | -2,09% | 3,21% | 433.772 |
| 14/07/2016 | 79,58 | 80,68 | 78,37 | 80,30 | +3,04% | 2,90% | 1.082.827 |
| 13/07/2016 | 80,46 | 80,47 | 77,81 | 77,93 | -2,66% | 3,31% | 709.969 |
| 12/07/2016 | 80,79 | 81,07 | 79,24 | 80,06 | +1,24% | 2,27% | 645.528 |
| 11/07/2016 | 79,04 | 79,59 | 77,89 | 79,08 | +0,72% | 2,15% | 1.045.797 |
| 08/07/2016 | 77,06 | 78,71 | 76,54 | 78,52 | +1,72% | 2,81% | 512.319 |
| 07/07/2016 | 77,84 | 77,87 | 75,51 | 77,19 | -0,02% | 3,02% | 459.260 |
| 06/07/2016 | 76,30 | 77,82 | 75,96 | 77,20 | +0,80% | 2,44% | 453.489 |
| 05/07/2016 | 76,17 | 77,02 | 75,49 | 76,59 | +0,53% | 2,01% | 496.930 |
| 01/07/2016 | 74,40 | 76,59 | 74,25 | 76,18 | +2,39% | 3,14% | 513.281 |
| 30/06/2016 | 75,86 | 75,86 | 73,66 | 74,40 | -1,77% | 2,91% | 681.596 |
| 29/06/2016 | 74,15 | 76,09 | 73,43 | 75,75 | +3,21% | 3,59% | 957.151 |
| 28/06/2016 | 71,70 | 73,44 | 70,92 | 73,39 | +4,00% | 3,51% | 627.575 |
| 27/06/2016 | 69,31 | 72,06 | 68,38 | 70,57 | +1,19% | 5,31% | 719.747 |
| 24/06/2016 | 69,27 | 71,43 | 68,63 | 69,74 | -2,88% | 4,04% | 864.658 |
| 23/06/2016 | 71,62 | 72,11 | 71,00 | 71,81 | +1,12% | 1,56% | 390.010 |
| 22/06/2016 | 70,97 | 72,89 | 70,42 | 71,01 | -0,14% | 3,49% | 552.714 |